GlassScriptPhysician profile
Jacqueline M Carter
NPI 1669468807
$1,810.76
in general payments reported to CMS, 2019-2025
20 companies · $16.76 in 2025
The $16.76 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,444 · 2020: $242 · 2022: $19.60 · 2023: $88.26 · 2025: $16.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $759.34 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.12 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $128.01 | 2019-2020 | |
| Lilly USA, LLC | $127.23 | 2019-2020 | |
| Novo Nordisk INC | $98.50 | 2019-2020 | |
| Amgen INC. | $61.79 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $56.38 | 2019-2020 | |
| Organon LLC | $49.67 | 2023 | Nexplanon |
| Novartis Pharmaceuticals Corporation | $41.35 | 2019 | |
| Sarepta Therapeutics, INC. | $41.29 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.59 | 2023 | Advate |
| Abbott Laboratories | $36.21 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $34.72 | 2019-2020 | |
| Glaxosmithkline, LLC. | $31.09 | 2019-2020 | |
| Nevro Corp. | $28.46 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $22.80 | 2019 | |
| Allergan, INC. | $17.42 | 2020 | |
| Philips North America LLC | $17.35 | 2019 | |
| Endotronix, INC. | $16.76 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.